A detailed history of Thrivent Financial For Lutherans transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 24,603 shares of AGIO stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,603
Previous 24,603 -0.0%
Holding current value
$1.32 Million
Previous $1.06 Million 3.02%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$27.55 - $48.83 $28,955 - $51,320
-1,051 Reduced 4.1%
24,603 $1.06 Million
Q4 2023

Feb 14, 2024

SELL
$19.97 - $24.53 $382,445 - $469,774
-19,151 Reduced 42.74%
25,654 $572,000
Q3 2023

Nov 14, 2023

BUY
$24.36 - $28.18 $535 - $619
22 Added 0.05%
44,805 $1.11 Million
Q2 2023

Aug 14, 2023

SELL
$21.38 - $29.19 $46,950 - $64,101
-2,196 Reduced 4.67%
44,783 $1.27 Million
Q4 2022

Feb 08, 2023

SELL
$24.81 - $31.52 $13,992 - $17,777
-564 Reduced 1.19%
46,979 $1.32 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $1.09 Million - $1.9 Million
-55,776 Reduced 53.98%
47,543 $1.34 Million
Q2 2022

Aug 16, 2022

BUY
$17.06 - $31.42 $1.76 Million - $3.25 Million
103,319 New
103,319 $2.29 Million
Q1 2021

May 17, 2021

SELL
$44.23 - $57.5 $15.5 Million - $20.2 Million
-350,768 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.21 - $46.54 $2.88 Million - $4.04 Million
86,829 Added 32.9%
350,768 $15.2 Million
Q3 2020

Nov 10, 2020

SELL
$33.87 - $55.93 $241,120 - $398,165
-7,119 Reduced 2.63%
263,939 $9.24 Million
Q2 2020

Aug 12, 2020

BUY
$34.45 - $53.48 $47,782 - $74,176
1,387 Added 0.51%
271,058 $14.5 Million
Q1 2020

May 15, 2020

BUY
$31.52 - $53.81 $29,565 - $50,473
938 Added 0.35%
269,671 $9.57 Million
Q4 2019

Feb 13, 2020

BUY
$30.08 - $50.59 $870,635 - $1.46 Million
28,944 Added 12.07%
268,733 $12.8 Million
Q3 2019

Nov 14, 2019

BUY
$32.4 - $49.58 $7.77 Million - $11.9 Million
239,789 New
239,789 $7.77 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.95B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.